The Claim
In adults with bipolar depression receiving standard pharmacotherapy, adjunctive creatine monohydrate at 6 g daily for 6 weeks was associated with a 52.9% remission rate (MADRS ≤12) compared to an 11.1% remission rate in placebo, based on intention-to-treat analysis of 35 participants.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults with bipolar depression on standard medication, taking 6 grams of creatine daily for six weeks was linked to a 52.9% rate of symptom remission, while those taking a placebo had an 11.1% remission rate.
See the scientific wording
In adults with bipolar depression receiving standard pharmacotherapy, adjunctive creatine monohydrate at 6 g daily for 6 weeks was associated with a 52.9% remission rate (MADRS ≤12) compared to 11.1% in placebo, based on intention-to-treat analysis of 35 participants, suggesting a potential benefit for treatment-resistant depressive episodes despite no significant change in mean MADRS scores.
Creatine enters the brain and boosts the supply of energy molecules that neurons need to function, while also neutralizing harmful chemicals that damage brain cells. This helps neurons in mood-control areas of the brain work properly again, leading to a sharp drop in depression symptoms for some people.
What the research says
1 studyIn people with bipolar depression who weren't getting better with their usual meds, taking creatine for six weeks made them much more likely to have very low depression scores than those taking a fake pill—even though the average depression score didn't drop much for everyone. So creatine helped some people get much better.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.